Mulakan
ReutersReuters

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation

RefinitivBacaan kurang dari 1 minit
GUTS

Fractyl Health Inc GUTS:

  • FRACTYL HEALTH ANNOUNCES GROUNDBREAKING DATA FROM REMAIN-1 MIDPOINT COHORT SHOWING REVITA® MAINTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION

  • FRACTYL HEALTH INC - STUDY MET 3-MONTH EFFICACY ENDPOINT WITH STRONG STATISTICAL SIGNIFICANCE

  • FRACTYL HEALTH INC - REVITA PROCEDURE DEMONSTRATED EXCELLENT SAFETY AND TOLERABILITY TO DATE

ReutersSaham AS
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters